Park Ha Biological Technology Co., Ltd. Asset Resilience Ratio
Park Ha Biological Technology Co., Ltd. asset resilience ratio. Park Ha Biological Technology Co., Ltd. (PHH) has an Asset Resilience Ratio of 2.84% as of June 2018. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See defensive interval ratio of Park Ha Biological Technology Co., Ltd. to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Park Ha Biological Technology Co., Ltd. (2004–2017)
Asset resilience ratio of Park Ha Biological Technology Co., Ltd. from 2004 to 2017. This chart shows how Park Ha Biological Technology Co., Ltd.'s Asset Resilience Ratio has changed over time. Read PHH liabilities breakdown for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Park Ha Biological Technology Co., Ltd.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see balance sheet size of Park Ha Biological Technology Co., Ltd..
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $41.00 Million | 2.84% |
| Total Liquid Assets | $41.00 Million | 2.84% |
Asset Resilience Insights
- Limited Liquidity: Park Ha Biological Technology Co., Ltd. maintains only 2.84% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Park Ha Biological Technology Co., Ltd. Industry Peers by Asset Resilience Ratio
Compare Park Ha Biological Technology Co., Ltd.'s asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Taiyen Biotech Co Ltd
TW:1737 |
Household & Personal Products | 4.73% |
|
Delko S.A.
WAR:DEL |
Household & Personal Products | -0.08% |
|
Rigolleau SA
BA:RIGO |
Household & Personal Products | 0.27% |
|
Star Combo Pharma Ltd
AU:S66 |
Household & Personal Products | 30.02% |
|
Mcphersons Ltd
AU:MCP |
Household & Personal Products | 10.94% |
|
ZOONO Group Ltd
AU:ZNO |
Household & Personal Products | 9.18% |
|
Skin Elements Ltd
AU:SKN |
Household & Personal Products | 21.26% |
|
Ontex Group NV
BR:ONTEX |
Household & Personal Products | 1.55% |
Park Ha Biological Technology Co., Ltd. Asset Resilience Ratio by Year (2004–2017)
Park Ha Biological Technology Co., Ltd. asset resilience ratio by year from 2004 to 2017. The table below shows the annual Asset Resilience Ratio data for Park Ha Biological Technology Co., Ltd..
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2017-12-31 | 2.26% | $41.00 Million | $1.81 Billion | +0.47pp |
| 2016-12-31 | 1.80% | $57.00 Million | $3.17 Billion | +0.51pp |
| 2015-12-31 | 1.29% | $47.00 Million | $3.65 Billion | -0.02pp |
| 2014-12-31 | 1.30% | $56.00 Million | $4.30 Billion | -1.34pp |
| 2013-12-31 | 2.64% | $234.00 Million | $8.85 Billion | -0.52pp |
| 2012-12-31 | 3.17% | $304.00 Million | $9.60 Billion | -0.39pp |
| 2011-12-31 | 3.56% | $348.00 Million | $9.78 Billion | +1.10pp |
| 2010-12-31 | 2.46% | $277.00 Million | $11.27 Billion | -4.88pp |
| 2009-12-31 | 7.34% | $596.00 Million | $8.12 Billion | -0.08pp |
| 2008-12-31 | 7.42% | $614.00 Million | $8.27 Billion | +1.23pp |
| 2007-12-31 | 6.19% | $579.00 Million | $9.36 Billion | +0.99pp |
| 2006-12-31 | 5.20% | $559.00 Million | $10.76 Billion | +0.21pp |
| 2005-12-31 | 4.99% | $497.00 Million | $9.96 Billion | -2.62pp |
| 2004-12-31 | 7.61% | $876.00 Million | $11.52 Billion | -- |
About Park Ha Biological Technology Co., Ltd.
Park Ha Biological Technology Co., Ltd., investment holding company, develops skincare products in the People's Republic of China. The company operates in two segments, Product Sales and Franchise Service. It offers various products, such as basic skin physical protection, exfoliation, and sebum film repair to surface microecological balance, and anti-aging under the Park Ha brand. It sells produ… Read more